Market Cap : 434.6 B | Enterprise Value : 434.63 B | PE Ratio : 24.06 | PB Ratio : 5.69 |
---|
NYSE:JNJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Johnson & Johnson has the Financial Strength Rank of 7.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.Johnson & Johnson's Interest Coverage for the quarter that ended in Jun. 2022 was 162.42. Johnson & Johnson's debt to revenue ratio for the quarter that ended in Jun. 2022 was 0.34. As of today, Johnson & Johnson's Altman Z-Score is 4.61.
For the Drug Manufacturers - General subindustry, Johnson & Johnson's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Financial Strength distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Johnson & Johnson's Interest Expense for the months ended in Jun. 2022 was $-38 Mil. Its Operating Income for the months ended in Jun. 2022 was $6,172 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $28,292 Mil.
Johnson & Johnson's Interest Coverage for the quarter that ended in Jun. 2022 is
Interest Coverage | = | -1 | * | Operating Income (Q: Jun. 2022 ) | / | Interest Expense (Q: Jun. 2022 ) |
= | -1 | * | 6172 | / | -38 | |
= | 162.42 |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Johnson & Johnson's Debt to Revenue Ratio for the quarter that ended in Jun. 2022 is
Debt to Revenue Ratio | = | Total Debt (Q: Jun. 2022 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (4305 | + | 28292) | / | 96080 | |
= | 0.34 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Johnson & Johnson has a Z-score of 4.61, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 4.61 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Johnson & Johnson has the Financial Strength Rank of 7.
Thank you for viewing the detailed overview of Johnson & Johnson's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Adamczyk Darius | director | 855 S. MINT STREET CHARLOTTE NC 28202 |
Hait William | officer: See Remarks | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mammen Mathai | officer: EVP, Pharm, R&D | THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 |
Broadhurst Vanessa | officer: EVP, Global Corp Aff. | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Swanson James D. | officer: EVP, Chief Information Officer | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
West Nadja | director | 1915 REXFORD ROAD CHARLOTTE NC 28211 |
Decker Robert J | officer: Controller, CAO | ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Joly Hubert | director | C/O BEST BUY CO, INC. 7601 PENN AVENUE SOUTH RICHFIELD MN 55423 |
Weinberger Mark A | director | METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166 |
Hewson Marillyn A | director | C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662 |
Mongon Thibaut | officer: Exec VP, WW Chair, Consumer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wengel Kathryn E | officer: EVP, Chief GSC Officer | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Wolk Joseph J | officer: Exec VP, CFO | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Mcevoy Ashley | officer: EVP, WW Chair, Medical Devices | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
Taubert Jennifer L | officer: EVP, WW Chair, Pharmaceuticals | JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 |
From GuruFocus
Other Sources
By Zacks 2022-03-30
By Zacks 2022-03-16
By Zacks 2022-03-24
By Zacks 2022-03-28
By Zacks 2022-03-22
By tipranks.com 2022-04-01
By Zacks 2022-03-15
By Zacks 2022-03-16
By Zacks 2022-03-24
By Zacks 2022-03-21
By Zacks 2022-03-18
By Zacks 2022-04-04
By Zacks 2022-03-14
By Zacks 2022-04-06